Jiangsu wuzhong(600200)
Search documents
A股平均股价14.08元 20股股价不足2元
Zheng Quan Shi Bao Wang· 2025-11-13 08:33
Core Viewpoint - The average stock price in the A-share market is 14.08 yuan, with 20 stocks priced below 2 yuan, the lowest being *ST Yuan Cheng at 0.58 yuan [1] Summary by Category Stock Price Distribution - As of November 13, the Shanghai Composite Index closed at 4029.50 points, with the average A-share price at 14.08 yuan [1] - There are 20 stocks priced below 2 yuan, with *ST Yuan Cheng being the lowest at 0.58 yuan, followed by *ST Su Wu at 0.98 yuan and *ST Jin Ke at 1.47 yuan [1] - Among the low-priced stocks, 8 are ST stocks, accounting for 40% of the total [1] Market Performance - Out of the low-priced stocks, 16 saw an increase today, with the highest gains from ST Yi Gou (5.29%), *ST Jin Ke (5.00%), and Rongsheng Development (4.73%) [1] - Only 2 stocks experienced a decline, with ST Ling Nan and *ST Hui Feng dropping by 1.03% and 0.53%, respectively [1] Low-Priced Stock Rankings - A detailed ranking of low-priced stocks includes: - *ST Yuan Cheng: Latest closing price 0.58 yuan, market-to-book ratio 0.27, industry: construction decoration [1] - *ST Su Wu: Latest closing price 0.98 yuan, daily turnover rate 1.97%, industry: pharmaceutical [1] - *ST Jin Ke: Latest closing price 1.47 yuan, daily increase 5.00%, industry: real estate [1] - Other notable stocks include Chongqing Steel (1.59 yuan), Yongtai Energy (1.63 yuan), and Shandong Steel (1.65 yuan) [1]
A股平均股价13.93元 20股股价不足2元
Zheng Quan Shi Bao Wang· 2025-11-12 09:24
Core Points - The average stock price of A-shares is 13.93 yuan, with 20 stocks priced below 2 yuan, the lowest being *ST Yuan Cheng at 0.58 yuan [1] - As of November 12, the Shanghai Composite Index closed at 4000.14 points, indicating a relatively low proportion of both high-priced and low-priced stocks in the A-share market [1] - Among the low-priced stocks, 8 are ST stocks, accounting for 40% of the total [1] Low-Priced Stocks Summary - The lowest priced stock is *ST Yuan Cheng at 0.58 yuan, followed by *ST Su Wu at 0.98 yuan and *ST Jin Ke at 1.40 yuan [1] - In terms of market performance, 4 of the low-priced stocks increased in price, with Haihang Holdings, *ST Hui Feng, and *ST Su Wu showing gains of 1.09%, 1.08%, and 1.03% respectively [1] - Conversely, 12 stocks declined, with Chongqing Steel, Rongsheng Development, and Yabo Co. experiencing drops of 1.88%, 1.74%, and 1.53% respectively [1] Low-Priced Stocks Table - The table lists various low-priced stocks along with their latest closing prices, daily price changes, turnover rates, price-to-book ratios, and industries [1]
341只个股流通市值不足20亿元
Zheng Quan Shi Bao Wang· 2025-11-12 02:23
Core Insights - Small-cap stocks exhibit higher volatility and activity compared to large-cap stocks, making them more likely to become market leaders [1] - As of November 11, there are 880 stocks with a circulating market value below 3 billion yuan, and 341 stocks with a circulating market value below 2 billion yuan [1] - A total of 1,605 stocks have a total market value below 5 billion yuan, with 492 stocks having a total market value below 3 billion yuan [1] Market Data - The three stocks with the smallest circulating market values are *ST Yuan Cheng at 189 million yuan, Kuntai Co. at 668 million yuan, and *ST Su Wu at 690 million yuan [1] - The three stocks with the smallest total market values are also *ST Yuan Cheng at 189 million yuan, *ST Su Wu at 690 million yuan, and *ST Chang Yao at 774 million yuan [1] - A detailed list of stocks with circulating market values below 2 billion yuan includes various sectors such as construction decoration, automotive, and pharmaceuticals, with notable examples like Kuntai Co. having a P/E ratio of 48.57 [1][2]
A股平均股价13.96元 21股股价不足2元





Zheng Quan Shi Bao Wang· 2025-11-11 08:43
Core Insights - The average stock price in the A-share market is 13.96 yuan, with 21 stocks priced below 2 yuan, the lowest being *ST Yuan Cheng at 0.58 yuan [1][1][1] Low-Priced Stocks Overview - Among the low-priced stocks, 9 are ST stocks, accounting for 42.86% of those priced below 2 yuan [1][1] - The stocks with the highest daily gains include Yabo Co., ST Zhongzhu, and Chongqing Steel, with increases of 4.81%, 2.06%, and 1.91% respectively [1][1] - The stocks with the largest declines are *ST Suwu, Yongtai Energy, and HNA Holding, with decreases of 1.02%, 0.61%, and 0.54% respectively [1][1] Low-Priced Stocks Ranking - The table lists various low-priced stocks along with their latest closing prices, daily change percentages, turnover rates, price-to-book ratios, and industries, highlighting the performance of these stocks in the market [1][1][1]
349只个股流通市值不足20亿元
Zheng Quan Shi Bao Wang· 2025-11-11 01:45
Core Insights - Small-cap stocks exhibit higher volatility and activity compared to large-cap stocks, making them more likely to become market leaders [1] Market Overview - As of November 10, there are 894 stocks with a circulating market value below 3 billion yuan, and 349 stocks with a circulating market value below 2 billion yuan [1] - A total of 1,605 stocks have a total market value below 5 billion yuan, with 502 stocks having a total market value below 3 billion yuan [1] Smallest Market Capitalization Stocks - The three stocks with the smallest circulating market values are *ST元成 at 189 million yuan, 坤泰股份 at 665 million yuan, and *ST苏吴 at 697 million yuan [1] - The three stocks with the smallest total market values are also *ST元成 at 189 million yuan, *ST苏吴 at 697 million yuan, and *ST长药 at 967 million yuan [1] Selected Stocks with Low Market Value - A list of stocks with circulating market values below 2 billion yuan includes: - *ST元成: circulating market value 189 million yuan, total market value 189 million yuan, P/E ratio not applicable, industry: construction decoration [1] - 坤泰股份: circulating market value 665 million yuan, total market value 2.407 billion yuan, P/E ratio 48.34, industry: automotive [1] - *ST苏吴: circulating market value 697 million yuan, total market value 697 million yuan, P/E ratio not applicable, industry: pharmaceutical [1] - 康力源: circulating market value 706 million yuan, total market value 2.763 billion yuan, P/E ratio 36.55, industry: light industry manufacturing [1] - 科瑞思: circulating market value 736 million yuan, total market value 2.503 billion yuan, P/E ratio 179.99, industry: communication [1] - 鸿铭股份: circulating market value 753 million yuan, total market value 2.290 billion yuan, P/E ratio not applicable, industry: machinery [1] - 扬州金泉: circulating market value 771 million yuan, total market value 3.078 billion yuan, P/E ratio 26.84, industry: textile and apparel [1] - 万得凯: circulating market value 797 million yuan, total market value 3.138 billion yuan, P/E ratio 28.15, industry: machinery [1] - 播恩集团: circulating market value 809 million yuan, total market value 2.335 billion yuan, P/E ratio not applicable, industry: agriculture, forestry, animal husbandry, and fishery [1] - 美硕科技: circulating market value 833 million yuan, total market value 2.856 billion yuan, P/E ratio 104.54, industry: power equipment [1]
江苏吴中医药发展股份有限公司 关于公司股票可能存在因股价低于1元而终止上市的风险提示公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-11-08 00:24
Group 1 - The company's stock closed at 0.98 CNY per share on November 7, 2025, which is below the 1 CNY threshold, potentially leading to delisting if it remains below this price for 20 consecutive trading days [2][5] - The company received an administrative penalty notice from the China Securities Regulatory Commission on July 13, 2025, indicating that it inflated revenue, costs, and profits, with false records in annual reports from 2020 to 2023 [5][6] - The company is subject to a risk warning for delisting due to significant violations, as per the Shanghai Stock Exchange regulations, and has been under a delisting risk warning since July 14, 2025 [5][4] Group 2 - According to the Shanghai Stock Exchange rules, if a company's stock price falls below 1 CNY for 20 consecutive trading days, it may face termination of listing [2][3] - The company is required to disclose risk warning announcements if its stock price falls below 1 CNY, with specific disclosure requirements based on the duration of the price drop [3][4] - The company has designated information disclosure media, including the China Securities Journal and the Shanghai Securities Journal, for communicating relevant information to investors [5][6]
A股平均股价13.95元 25股股价不足2元
Zheng Quan Shi Bao Wang· 2025-11-07 09:11
Core Insights - The average stock price in the A-share market is 13.95 yuan, with 25 stocks priced below 2 yuan, the lowest being *ST Gao Hong at 0.38 yuan [1][2] - Among the low-priced stocks, 10 are ST stocks, accounting for 40% of the total [1] Market Performance - As of November 7, the Shanghai Composite Index closed at 3997.56 points [1] - In the low-priced stock category, 8 stocks increased in price, with *ST Hui Feng leading at a rise of 3.53%, followed by ST Jing Lan at 1.71% and HNA Holding at 1.67% [1] - Conversely, 10 stocks experienced declines, with *ST Yuan Cheng dropping 4.69%, *ST Su Wu down 2.00%, and ST Zhong Zhu falling 1.51% [1] Low-Priced Stock Rankings - The table lists various low-priced stocks, including their latest closing prices, daily price changes, turnover rates, price-to-book ratios, and industries [1][2] - Notable low-priced stocks include *ST Gao Hong (0.38 yuan), *ST Yuan Cheng (0.61 yuan), and *ST Su Wu (0.98 yuan) [1]
*ST苏吴(600200) - 江苏吴中医药发展股份有限公司关于公司股票可能存在因股价低于1元而终止上市的风险提示公告
2025-11-07 09:02
证券代码:600200 证券简称:*ST 苏吴 公告编号:临 2025-131 江苏吴中医药发展股份有限公司关于公司股票 可能存在因股价低于 1 元而终止上市的风险提示公告 根据《股票上市规则》第 9.2.1 条第一款的规定:在上交所仅发行 A 股股票 的上市公司,如果连续 20 个交易日的每日股票收盘价均低于 1 元,公司股票可 能被上交所终止上市交易。公司股票 2025 年 11 月 7 日收盘价为 0.98 元/股,低 于人民币 1 元。如果出现"连续 20 个交易日的每日股票收盘价均低于人民币 1 元"的情形,公司股票可能被上交所终止上市交易。 江苏吴中医药发展股份有限公司(以下简称"公司")股票 2025 年 11 月 7 日收盘价为 0.98 元/股,低于人民币 1 元。根据《上海证券交易所股 票上市规则》(以下简称"《股票上市规则》")第 9.2.1 条第一款第 一项规定,在上海证券交易所(以下简称"上交所")仅发行 A 股股票 的上市公司,如果连续 20 个交易日的每日股票收盘价均低于 1 元,公司 股票可能被上交所终止上市交易。根据《股票上市规则》第 9.6.1 条规 定,交易类强制退市公司 ...
江苏吴中医药发展股份有限公司 关于公司股票可能被实施重大违法强制退市的第十七次风险提示公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-11-06 23:21
Core Viewpoint - Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure, which may lead to significant penalties and potential delisting of its stock [2][4]. Group 1: Investigation and Regulatory Actions - The company received a notice from the CSRC on July 13, 2025, indicating that it had inflated revenue, costs, and profits in its annual reports from 2020 to 2023, which could trigger mandatory delisting due to serious violations [4][5]. - The company was formally notified of the investigation on February 26, 2025, due to allegations of information disclosure violations [3][4]. Group 2: Financial Irregularities - The inflated figures included revenue increases of CNY 495.26 million, CNY 468.51 million, CNY 430.75 million, and CNY 376.66 million for the years 2020 to 2023, representing 26.46%, 26.39%, 21.26%, and 16.82% of reported revenues respectively [4]. - The inflated costs were CNY 480.68 million, CNY 448.24 million, CNY 410.82 million, and CNY 355.44 million for the same years, accounting for 37.08%, 35.47%, 28.40%, and 20.95% of reported costs respectively [4]. - The total profit inflation was CNY 14.58 million, CNY 20.27 million, CNY 19.92 million, and CNY 21.22 million, which constituted 2.89%, 51.65%, 26.42%, and 29.81% of reported profits respectively [4]. Group 3: Current Risks and Financial Status - The company faces multiple delisting risks, including major violations, financial delisting, and face value delisting, alongside unresolved issues related to significant fund occupation by controlling shareholders [3][6]. - As of the end of 2023, the controlling shareholder's non-operational fund occupation amounted to CNY 1.69 billion, which remains unresolved [6]. - The company reported a net loss of CNY 87.47 million for the first three quarters of 2025, a decline of 294.03% compared to the same period last year [6].
*ST苏吴(600200) - 江苏吴中医药发展股份有限公司关于公司股票可能被实施重大违法强制退市的第十七次风险提示公告
2025-11-06 16:01
证券代码:600200 证券简称:*ST 苏吴 公告编号:临 2025-130 截至本公告披露日,公司尚未收到就上述立案调查事项的正式处罚决定,公 司将全力配合中国证监会的相关工作,并严格按照相关要求履行信息披露义务。 如根据正式的行政处罚决定书结论,公司触及重大违法强制退市情形,公司股票 将被终止上市。 二、风险提示 (一)公司存在财务类退市风险 公司 2024 年度财务报告被年审机构出具无法表示意见,触及《上海证券交 易所股票上市规则》第 9.3.2 条第(三)项规定财务类退市的情形,公司股票已 被上海证券交易所实施退市风险警示。具体内容详见公司于 2025 年 4 月 30 日披 露的《关于实施退市风险警示及叠加其他风险警示暨停牌的公告》(公告编号: 临 2025-032)。 江苏吴中医药发展股份有限公司关于公司股票 可能被实施重大违法强制退市的第十七次风险提示公告 本公司董事会及董事会全体成员保证公告内容不存在虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实、准确和完整承担法律责任。 重要风险提示: 江苏吴中医药发展股份有限公司(以下简称"公司")因涉嫌信息披露违 法违规,被中国证券监督管理委员会 ...